You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple Sclerosis (MS)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Cognitive Dysfunction, Memory Disorders Trial (HOme-Based Self-management and COgnitive Training CHanges

Not yet recruiting
  • Multiple Sclerosis
  • +2 more
  • HOme-Based Self-management and COgnitive Training CHanges lives (HOBSCOTCH)
  • (no location specified)
Nov 17, 2023

Detecting Changes in Multiple Sclerosis (MS) Condition

Not yet recruiting
  • Multiple Sclerosis
    • (no location specified)
    Mar 10, 2023

    Corrona Multiple Sclerosis (MS) Registry

    Enrolling by invitation
    • Multiple Sclerosis
      • Waltham, Massachusetts
        Corrona, LLC
      Nov 9, 2022

      Integrated Digital Solutions in Medical Care of Multiple

      Not yet recruiting
      • Relapsing Remitting Multiple Sclerosis
      • MS Care Platform (icobrain ms and icompanion ms)
      • (no location specified)
      Jul 10, 2023

      Multiple Sclerosis (MS) Patients

      Not yet recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • +2 more
        • (no location specified)
        Dec 15, 2022

        Quality of Life of Multiple Sclerosis Patients Treated With

        Not yet recruiting
        • Multiple Sclerosis (MS)
        • ofatumumab
        • (no location specified)
        Nov 27, 2023

        Multiple Sclerosis Trial in New York (Active tDCS, Sham () stimulation)

        Recruiting
        • Multiple Sclerosis
        • Active tDCS
        • Sham (placebo) stimulation
        • New York, New York
          New York University School of Medicine
        Dec 28, 2022

        Multiple Sclerosis Trial in Calgary (SIMBA Capsule)

        Not yet recruiting
        • Multiple Sclerosis
        • SIMBA Capsule
        • Calgary, Alberta, Canada
          University of Calgary
        Apr 25, 2023

        End of Dose Phenomena in Subcutaneous Natalizumab Treated

        Not yet recruiting
        • Multiple Sclerosis
        • (no location specified)
        Jan 18, 2023

        Multiple Sclerosis Trial in East Hanover (Unified Protocol)

        Recruiting
        • Multiple Sclerosis
        • Unified Protocol
        • East Hanover, New Jersey
          Kessler Foundation
        Jul 12, 2023

        Trabecular Bone Score in Multiple Sclerosis

        Completed
        • Multiple Sclerosis
        • +2 more
        • sm tbs group
        • Messina, Italy
          IRCCS Centro Neurolesi Bonino Pulejo
        Mar 31, 2023

        Microparticle Delivered STING Agonist in Control of Experimental

        Recruiting
        • Relapse Remitting Multiple Sclerosis
        • Blood Draw
        • Philadelphia, Pennsylvania
          Thomas Jefferson University
        Jan 20, 2023

        Multimodal Imaging Signatures of Biological Mechanisms

        Not yet recruiting
        • Multiple Sclerosis (MS)
        • MRI
        • (no location specified)
        Jan 12, 2023

        Multiple Sclerosis (MS) Trial in Birmingham (Physical activity behavioral intervention in persons newly diagnosed with MS)

        Recruiting
        • Multiple Sclerosis (MS)
        • Physical activity behavioral intervention in persons newly diagnosed with MS
        • Birmingham, Alabama
          University of Alabama at Birmingham
        Jan 24, 2023

        Multiple Sclerosis Trial in Pavia (18F-florbetaben PET/CT)

        Recruiting
        • Multiple Sclerosis
        • 18F-florbetaben PET/CT
        • Pavia, PV, Italy
          ICS Maugeri SpA SB IRCCS
        Mar 23, 2023

        Immunoglobulin DeficiencyTreatable Cause of Fatigue in Multiple

        Recruiting
        • Hypogammaglobulinemia
        • +2 more
        • Laboratory test
        • Bern, BE, Switzerland
          University Hospital of Bern Inselspital
        Sep 26, 2022

        Multiple Sclerosis Trial (Natalizumab)

        Not yet recruiting
        • Multiple Sclerosis
        • (no location specified)
        Jun 21, 2023

        Long-Term Safety of Vumerity and Tecfidera in Multiple Sclerosis

        Not yet recruiting
        • Multiple Sclerosis
        • Diroximel Fumarate
        • +2 more
        • (no location specified)
        Mar 2, 2023

        Magnetic Resonance Imaging to Evaluate Activity of Multiple

        Recruiting
        • Multiple Sclerosis
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 30, 2023

          Ocrelizumab Effects on the Metabolome in MS

          Active, not recruiting
          • Multiple Sclerosis
          • Baltimore, Maryland
            Johns Hopkins University
          Jan 30, 2023

          Program Study for Improvement of Gait in People With Multiple

          Not yet recruiting
          • Gait Impairment Due to Mild/Moderate Multiple Sclerosis (MS)
          • PoNS®
          • (no location specified)
          Jun 23, 2022

          Multiple Sclerosis Trial in Bordeaux (Anti-Mullerian hormone (AMH) level, Antral follicle count (AFC), Clinical assessment)

          Not yet recruiting
          • Multiple Sclerosis
          • Anti-Mullerian hormone (AMH) level
          • +2 more
          • Bordeaux, France
            CHU de Bordeaux - service de neurologie
          Mar 6, 2023

          Relapsing Remitting Multiple Sclerosis Trial in Portland (3 mg Melatonin, 5 mg Melatonin)

          Active, not recruiting
          • Relapsing Remitting Multiple Sclerosis
          • 3 mg Melatonin
          • 5 mg Melatonin
          • Portland, Oregon
            Providence MS Center
          May 5, 2022

          Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

          Not yet recruiting
          • Multiple Sclerosis (MS)
          • +6 more
          • Clemastine Fumarate
          • Placebo
          • San Francisco, California
            Sandler Neurosciences Building, Neurological Clinical Research U
          Jan 23, 2023

          Multiple Sclerosis Trial in New York (Vancomycin, Placebo)

          Not yet recruiting
          • Multiple Sclerosis
          • New York, New York
            Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mou
          Sep 12, 2022